接受体外膜氧合的COVID-19患者无肺动脉血栓的肺缺血:一项队列研究
该队列研究分析了2020年3月至5月间51例接受ECMO的COVID-19肺炎患者的胸部CT,评估肺缺血的发生率及其与肺动脉血栓的关系。结果显示18/51(35.3%)有宏观血栓形成(15例伴缺血),13/51(25.5%)无相关血栓但存在缺血,结论认为多数接受ECMO的COVID-19患者实变肺内存在缺血区,近半数无供血肺动脉血栓,高度提示孤立性微血管免疫血栓所致肺缺血。
要点
- 接受ECMO的COVID-19患者中,35.3%(18/51)存在宏观肺动脉血栓,其中15例伴肺缺血。
- 25.5%(13/51)的患者存在肺缺血但无相关肺动脉血栓。
- 多数患者实变肺内可见缺血区,近半数无供血肺动脉血栓,提示微血管免疫血栓可能。
核心结论
- 多数接受ECMO的COVID-19患者实变肺内存在缺血区,近半数无供血肺动脉血栓,高度提示孤立性微血管免疫血栓所致肺缺血,但这些发现的预后意义尚不明确。
研究设计与样本
- 队列研究,纳入2020年3月至5月间51例确诊COVID-19肺炎并接受ECMO的患者,分析其胸部CT以评估肺血栓栓塞性疾病的存在与范围。
- 患者平均年龄45岁(范围26-66岁),38/51(74.5%)为男性,所有患者均为重症COVID-19肺炎。
关键影像表现/征象
- 18/51(35.3%)患者存在宏观血栓形成,其中15例伴有缺血。
- 13/51(25.5%)患者存在缺血但无相关血栓。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To evaluate the incidence of pulmonary ischaemia in COVID-19 patients on extracorporeal membrane oxygenation (ECMO), and its correlation with pulmonary artery thrombosis.
MATERIALS AND METHODS: Computed tomography (CT) thorax of all patients receiving ECMO with proven COVID-19 pneumonitis between March and May 2020 were analysed for the presence and extension of pulmonary thromboembolic disease.
RESULTS: Fifty-one patients were reviewed. The mean (range) age of 45 (26-66) years; 38/51 (74.5%) were men. All patients had severe COVID-19 pneumonitis, and 18/51 (35.3%) had macroscopic thrombosis (15 with associated ischaemia); however, 13/51 (25.5%) patients had ischaemia without associated thrombus.
CONCLUSION: The majority of patients with COVID-19 who received ECMO had areas of ischaemia within consolidated lungs, almost half of these without subtending pulmonary artery thrombosis. Although the prognostic significance of these findings is unclear, they are highly suggestive of lung ischaemia due to isolated microvascular immune thrombosis.
引用
- Mak SM, Mak D, Hodson D, et al. Pulmonary ischaemia without pulmonary arterial thrombus in COVID-19 patients receiving extracorporeal membrane oxygenation: a cohort study. Clin Radiol. 2020. PMID: 32778329. doi:10.1016/j.crad.2020.07.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。